Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

But Hims & Hers' shares fell in after-hours trading as second-quarter projections fell short of analysts' expectations. The ...

Hims & Hers achieved 136% YoY subscriber growth and unveiled ambitious 2030 goals. Discover how precision medicine drives ...

Hims & Hers Health (HIMS) is outperforming and posting numbers that make you wonder why anyone still doubts the stock’s ...

GMA” caught up with the newly-crowned Super Bowl MVP at Walt Disney World after the Philadelphia Eagles’ big win against the Kansas City Chiefs. The tele-health company Hims & Hers Health is ...

Pharma giant Novo Nordisk is partnering with telehealth companies to expand access to its blockbuster weight loss drug Wegovy ...

Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...

Hims & Hers Health shares have surged 32.4% since Tuesday’s session open. The stock is gaining following a standout first-quarter earnings report released late Monday. Don’t miss this list of ...

During the quarter, its marketing spending soared 77% to $231 million; Hims ran a Super Bowl ad campaign, and spent heavily in specialty-specific marketing campaigns within weight loss.